Altimmune, Inc. (ALT)
NASDAQ·Healthcare·Biotechnology
$2.70
+3.11%
Mkt Cap $233.00M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (8 analysts)
$11.25
Range $2.50 – $20.00
Implied Upside
+316.4%
Consensus $11.25 vs current $2.70
NASDAQ·Healthcare·Biotechnology
$2.70
+3.11%
Mkt Cap $233.00M
Buy
3
Hold
0
Sell
0
Price Target (8 analysts)
$11.25
Range $2.50 – $20.00
+316.4%
Consensus $11.25 vs current $2.70